Atsure?

Atsure?
Product Description

Biocon offers a wide range of oncotherapeutic which includes atsure. Composition: gemcitabine hydrochloride usp equivalent to gemcitabine 200mg/1gm/1.4gm. Mechanism of action: emcitabine exhibits cell phase specificity, primarily killing cells undergoing dna synthesis (s-phase) and also blocking the progression of cells through the g1/s-phase boundary. Indications: for the treatment of breast cancer, pancreatic cancer, non-small cell lung cancer and ovarian cancer atsure? (gemcitabine for injection usp) is available in a vial containing gemcitabine hydrochloride usp equivalent to gemcitabine 200mg, 1g, 1.4g/ vial

Read more Show less

Biocon Limited

  • IN
  • 2015
    On CPHI since
Company types
Contract Service
Manufacturer/Innovator
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Quality Service
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

Biocon Limited

  • IN
  • 2015
    On CPHI since
Company types
Contract Service
Manufacturer/Innovator
View company profile

More Products from Biocon Limited (4)

  • ACTIBLOK AM

    Product ACTIBLOK AM

    Biocon offers a wide range of metabolic which includes actiblok am. Composition: metoprolol succinate 25/50 mg and amlodipine 5 mg tablets. Mechanism of action: metoprolol is a beta1-selective (cardioselective) adrenergic receptor blocking agent, amlodipine: amlodipine is a dihydropyridine calcium channel ...
  • ACTIBLOK-IPR

    Product ACTIBLOK-IPR

    Biocon offers a wide range of metabolic which includes actiblok-ipr. Composition: metoprolol extended release 25/50/100mg tablets. Mechanism of action: metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent. It competitively antagonizes catecholamines at peripheral (especiall...
  • Advacan

    Product Advacan

    Biocon offers a wide range of nephrology which includes advacan. Composition: each uncoated /coated tablet contains everolimus 0.5mg and 0.25mg. Mechanism of action: everolimus, a proliferation signal inhibitor, prevents allograft rejection in allotransplantation. It exerts its immunosuppressive effect by ...
  • ALZUMAb

    Product ALZUMAb

    Biocon offers a wide range of immunotherapy which includes alzumab?. Composition: each vial contains 25 mg of itolizumab. Itolizumab is a humanized recombinant anti-cd-6 monoclonal antibody. Each ml contains 5 mg of itolizumab for intravenous use. Mechanism of action: itolizumab is a humanized recombinant ...

Biocon Limited resources (1)